Antimicrobial resistance: More quick action is needed in BRICS and MINT economic transition countries

  03 October 2019

Antimicrobial resistance (AMR) is an urgent public health issue, as resistant genes and pathogens will cross borders and spread without action, threatening medical progress. Breakthrough drugs and treatments, particularly those causing immunosuppression or requiring invasive procedures, will be useless if patients receiving them die from untreatable infections. This challenge requires multidisciplinary integrated collaboration and cooperation at the global level.

Effective Surveillance  

Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
  • No costs (until year end 2019)

Festive Launch Database 19 Nov Symposium Dinner ‘Emerging Antimicrobials and Diagnostics in AMR 2019
Click to join the Symposium Dinner (to join the Symposium separate registration obligatory)

Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!